MRSA (CA-. MRSA), and streptococci. Coverage for gram negative organisms is clindamycin, change clindamycin to alternate active agent such as bactrim or.
Empiric MRSA coverage is not necessary for children who have uncomplicated skin infections. MRSA activity, or clindamycin. The children
Clindamycin for presumptive MRSA. TABLE 2: Children's Minnesota Data Recommended concurrent MRSA coverage if: Penetrating trauma, evidence of
While there are other single options for coverage, they either have suboptimal MRSA coverage (i.e. clindamycin and doxycycline) or are more expensive (i.e. linezolid). Without reliable ways to determine which patients need MRSA coverage, it is unclear which patients with uncomplicated cellulitis need to be discharged with MRSA coverage and
Spectrum: Fairly broad spectrum with some Staph and MRSA coverage, some gram negative coverage, and atypicals. coverage, or add Clindamycin or Metronidazole.
Clindamycin is a unique antibiotic with Gram-positive and MRSA coverage as well as broad anaerobic coverage. It acts by inhibiting the 50S (
MRSA (CA-. MRSA), and streptococci. Coverage for gram negative organisms is clindamycin, change clindamycin to alternate active agent such as bactrim or.
If concern for MRSA, use vancomycin instead of clindamycin and add anaerobic coverage with ○ Clindamycin 300 mg PO TID (covers MRSA). OR. ○ Amoxicillin/
clindamycin resistance if CA-MRSA is resistant to erythromycin. Extended antibiotic coverage for CA-MRSA is not warranted for nonsuppurative cellulitis.
Comments